Reducing Kappa1 Receptor Expression Increased Measured THC Antinociceptive Tolerance in Mice

An antisense experiment in mice found increased measured tolerance to THC antinociception after targeting the kappa1 opioid receptor. A mismatch control did not produce the same result, supporting a specific experimental interaction while leaving its full mechanism unresolved.

The intervention targeted receptor expression

The study used antisense oligodeoxynucleotides directed against the kappa1 receptor, an approach previously shown to reduce that receptor. This differs from administering a conventional antagonist or studying a lifelong knockout. The research question concerned the relationship between an opioid receptor pathway and repeated-THC adaptation.

The outcome was a potency estimate

THC's antinociceptive ED50 increased in antisense-treated but not mismatch-treated mice. ED50 describes a dose-response measure in the tested assay. An increase is consistent with needing more drug for a comparable measured effect, rather than proving that every THC response disappeared.

Receptor involvement was not a complete causal account

The authors suggested that reduced kappa receptor number could accompany THC tolerance. The abstract does not establish that loss of this receptor is the sole cause of tolerance, or that changing it would improve clinical pain treatment. Initial sensitivity, repeated exposure and the measured antinociceptive endpoint all remain relevant.

The experiment contributes a controlled molecular intervention and a useful mismatch comparison. It does not establish a human tolerance-reset strategy or imply that opioid receptor effects generalize to intoxication and cognition. Its conclusion belongs to the specific receptor manipulation and pain-response measurement.

Related: interpreting cannabis tolerance claims.

Research cited

Rowen DW; Embrey JP; Moore CH; Welch SP. Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance. Pharmacology, biochemistry, and behavior (1998). doi:10.1016/s0091-3057(97)00485-1. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

A female-rat feeding study found that THC increased fat intake in one access schedule while rimonabant reduced intake in another. The feeding history and experimental group mattered to the direction and persistence of the response. Limited access created different eating patterns Rats had unrestricted chow and water, with groups differing…

Spread the love

Read Article: THC and CB1 Blockade Changed Fat Intake Differently Across Feeding Schedules in Female Rats

mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

In a mouse THC study, mTOR inhibition prevented selected memory-related effects when given before exposure but did not prevent a residual cognitive deficit when introduced after chronic THC stopped. Timing changed the intervention's result. Acute effects separated by endpoint Temsirolimus prevented acute anxiety-like and amnesic-like effects. THC-related anxiolysis, hypothermia, reduced…

Spread the love

Read Article: mTOR Inhibition Prevented Some THC Memory Effects When Given Before Exposure, Not After Cessation

Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

A mouse study found that repeated lower-dose JZL184 preserved antinociceptive and gastroprotective effects that became tolerant under higher-dose regimens. The result supports a dose-dependent experimental window, not a validated human treatment schedule. Two disease-related models were used Researchers examined neuropathic pain after sciatic nerve constriction and gastric hemorrhage induced by…

Spread the love

Read Article: Partial MAGL Inhibition Preserved Repeated Pain-Response and Gastric Benefits in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us